Holen Sie sich die Stockscreener-App
17.09
2.58%
-0.4521
Schlusskurs vom Vortag:
$17.54
Offen:
$17
24-Stunden-Volumen:
5,372
Relative Volume:
1.54
Marktkapitalisierung:
$402.40M
Einnahmen:
$1.70M
Nettoeinkommen (Verlust:
$-47.01M
KGV:
-10.05
EPS:
-1.7
Netto-Cashflow:
$-157.28M
1W Leistung:
-5.49%
1M Leistung:
-10.32%
6M Leistung:
-12.97%
1J Leistung:
-9.54%
1-Tages-Spanne:
$16.65
$17.00
1-Wochen-Bereich:
$16.65
$18.13
52-Wochen-Spanne:
$13.30
$20.00
Puretech Health Plc Adr Stock (PRTC) Company Profile
Firmenname
Puretech Health Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare PRTC vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
16.65 | 423.91M | 1.70M | -47.01M | -157.28M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.56 | 122.71B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
765.85 | 82.91B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
765.93 | 50.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.64 | 43.42B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
318.65 | 38.98B | 4.98B | 69.60M | 525.67M | 0.5198 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
Puretech Health Plc Adr Aktie (PRTC) Neueste Nachrichten
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Update - MarketBeat
Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight - GlobeNewswire Inc.
PureTech Health (NASDAQ:PRTC) Shares Up 2%Here's Why - MarketBeat
PRTC Stock Price and Chart — NASDAQ:PRTC - TradingView — Track All Markets
PureTech Health (NASDAQ:PRTC) Trading Up 5.7%Here's Why - MarketBeat
PureTech Health (NASDAQ:PRTC) Trading Up 5.7% – Here’s Why - Defense World
PureTech CEO to present at J.P. Morgan Healthcare Conference By Investing.com - Investing.com India
PureTech CEO to present at J.P. Morgan Healthcare Conference - Investing.com
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference - Chartmill
PureTech Health plc (OTCMKTS:PTCHF) Sees Significant Decrease in Short Interest - Defense World
PureTech Health appoints Robert Lyne as permanent CEO - Investing.com
PureTech Health appoints Robert Lyne as permanent CEO By Investing.com - Investing.com India
PureTech Health (NASDAQ:PRTC) Trading Down 0.7% – Time to Sell? - Defense World
PureTech Health (NASDAQ:PRTC) Trading Down 0.7%Time to Sell? - MarketBeat
PureTech provides update on AGM results following shareholder concerns - Investing.com
PureTech stock falls after FDA meeting on IPF drug - Investing.com
PureTech Health (NASDAQ:PRTC) Trading 0.4% HigherStill a Buy? - MarketBeat
PureTech Health (NASDAQ:PRTC) Stock Price Up 3.1%Time to Buy? - MarketBeat
PureTech Health PLC Sponsored ADR $PRTC Shares Sold by Birch Hill Investment Advisors LLC - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 100.0% in September - MarketBeat
Free cash flow per share of PureTech Health PLC Sponsored ADR – NASDAQ:PRTC - TradingView
PureTech Health (NASDAQ:PRTC) Trading Up 3.6%Here's What Happened - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Significant Growth in Short Interest - MarketBeat
PureTech Health (LON:PRTC) Shares Up 14.2% – Should You Buy? - Defense World
PureTech Health Sees Strong Market Presence in FTSE All Share - Kalkine Media
Parallel Advisors LLC Acquires 1,718 Shares of GSK PLC Sponsored ADR $GSK - Defense World
What Makes PureTech Health (PRTC) a New Buy Stock - Yahoo Finance
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Large Growth in Short Interest - MarketBeat
BioHarvest Sciences (BHST) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
PureTech Health (NASDAQ:PRTC) Shares Up 4.7%Time to Buy? - MarketBeat
International Flavors & Fragrances (NYSE:IFF) & DAQO New Energy (NYSE:DQ) Critical Comparison - Defense World
Deupirfenidone: A Potential New Standard of Care - Placera.se
PureTech launches new entity to advance IPF treatment deupirfenidone - Investing.com
PureTech Health to report half-yearly results on August 28 - Investing.com
PureTech Health names Robert Lyne as interim CEO as Chowrira departs - Investing.com
PureTech Health announces board leadership transition - Investing.com
PureTech Health announces RSU vesting and share transactions by PDMR - Investing.com
Citius Oncology (CTOR) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
TuHURA Biosciences (HURA) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
PureTech Health enlists Peel Hunt as joint broker - Investing.com
Nordic Capital XI ends pursuit of PureTech acquisition - Investing.com
PureTech Health (LSE: PRTC) Presents Promising Phase 1b Data for LYT-200 in AML and MDS at ASH 2024 - Kalkine Media
India Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Argentina Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Norway Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Japan Anti-obesity Medication Market Size & Outlook, 2030 - Grand View Research
Mexico Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Asia Pacific Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Europe Anti-obesity Medication Market Size & Outlook, 2030 - Grand View Research
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - FinancialContent
symbol__ Stock Quote Price and Forecast - CNN
Finanzdaten der Puretech Health Plc Adr-Aktie (PRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):